| [1] |
Fraser S, Roderick PJ. Kidney disease in the global burden of disease study 2017 [J]. Nat Rev Nephrol, 2019, 15(4): 193-194.
|
| [2] |
Yun CW, Lee SH. Potential and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for acute/chronic kidney disease [J]. Int J Mol Sci, 2019, 20(7): 1619.
|
| [3] |
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet, 2020, 395(10225): 709-733.
|
| [4] |
Wang F, Preininger A. AI in health: state of the art, challenges, and future directions [J]. Yearb Med Inform, 2019, 28(1): 16-26.
|
| [5] |
Goecks J, Jalili V, Heiser LM, et al. How machine learning will transform biomedicine [J]. Cell, 2020, 181(1): 92-101.
|
| [6] |
Miller DD, Brown EW. Artificial intelligence in medical practice: the question to the answer [J]. Am J Med, 2018, 131(2): 129-133.
|
| [7] |
Attia ZI, Noseworthy PA, Lopez-Jimenez F, et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction [J]. Lancet, 2019, 394(10201): 861-867.
|
| [8] |
Sowah RA, Bampoe-Addo AA, Armoo SK, et al. Design and development of diabetes management system using machine learning [J]. Int J Telemed Appl, 2020, 2020: 8870141.
|
| [9] |
Bellemo V, Lim G, Rim TH, et al. Artificial intelligence screening for diabetic retinopathy: the real-world emerging application [J]. Curr Diab Rep, 2019, 19(9): 72.
|
| [10] |
Goodman S, Reid-Adam J. Immunoglobulin A nephropathy [J]. Pediatr Rev, 2019, 40(8): 439-441.
|
| [11] |
Rajasekaran A, Julian BA, Rizk DV. IgA nephropathy: an interesting autoimmune kidney disease [J]. Am J Med Sci, 2021, 361(2): 176-194.
|
| [12] |
Geddes CC, Fox JG, Allison ME, et al. An artificial neural network can select patients at high risk of developing progressive IgA nephropathy more accurately than experienced nephrologists [J]. Nephrol Dial Transplant, 1998, 13(1): 67-71.
|
| [13] |
Niel O, Boussard C, Bastard P. Artificial intelligence can predict GFR decline during the course of ADPKD [J]. Am J Kidney Dis, 2018, 71(6): 911-912.
|
| [14] |
Makino M, Yoshimoto R, Ono M, et al. Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning [J]. Sci Rep, 2019, 9(1): 11862.
|
| [15] |
Katsuki T, Ono M, Koseki A, et al. Risk prediction of diabetic nephropathy via interpretable feature extraction from EHR using convolutional autoencoder [J]. Stud Health Technol Inform, 2018, 247: 106-110.
|
| [16] |
Sabiu G, Podesta MA. Membranous nephropathy: it is time to go back to the future [J]. Nephron, 2021, 145(6): 721-727.
|
| [17] |
Ronco P, Debiec H. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care [J]. Lancet, 2015, 385(9981): 1983-1992.
|
| [18] |
Tu T, Wei X, Yang Y, et al. Deep learning-based framework for the distinction of membranous nephropathy: a new approach through hyperspectral imagery [J]. BMC Nephrol, 2021, 22(1): 231.
|
| [19] |
Chan L, Beers K, Yau AA, et al. Natural language processing of electronic health records is superior to billing codes to identify symptom burden in hemodialysis patients [J]. Kidney Int, 2020, 97(2): 383-392.
|
| [20] |
Khavanin Zadeh M, Omrani Z, Najmi N. Prevalence and survival of hemodialysis vascular access in end-stage renal disease (ESRD) patients of Tehran, Iran [J]. Ann Iran Med, 2006, 3(8): 37-40.
|
| [21] |
Viecelli AK, Lok CE. Hemodialysis vascular access in the elderly-getting it right [J]. Kidney Int, 2019, 95(1): 38-49.
|
| [22] |
Kim DH, Park JI, Lee JP, et al. The effects of vascular access types on the survival and quality of life and depression in the incident hemodialysis patients [J]. Ren Fail, 2020, 42(1): 30-39.
|
| [23] |
Gerald B. Fistula first has resulted in an Increase in catheter use [J]. J Vasc Access, 2009，10(4): 284-285.
|
| [24] |
Rezapour M, Khavanin ZM, Sepehri MM. Implementation of predictive data mining techniques for identifying risk factors of early AVF failure in hemodialysis patients [J]. Comput Math Methods Med, 2013, 2013: 830745.
|
| [25] |
Ota K, Nishiura Y, Ishihara S, et al. Evaluation of hemodialysis arteriovenous bruit by deep learning [J]. Sensors (Basel), 2020, 20(17): 4852.
|
| [26] |
Tsur N, Menashe I, Haviv YS. Risk factors before dialysis predominate as mortality predictors in diabetic maintenance dialysis patients [J]. Sci Rep, 2019, 9(1): 10633.
|
| [27] |
Garcia-Montemayor V, Martin-Malo A, Barbieri C, et al. Predicting mortality in hemodialysis patients using machine learning analysis [J]. Clin Kidney J, 2021, 14(5): 1388-1395.
|
| [28] |
Radovi N, Prelevi V, Erceg M, et al. Machine learning approach in mortality rate prediction for hemodialysis patients [J]. Comput Methods Biomech Biomed Engin, 2021, Epub ahead of print.
|
| [29] |
Sedaghattalab M, Razazan M, Sadeghi H, et al. Effects of nasturtium officinale extract on antioxidant and biochemical parameters in hemodialysis patients: a randomized double-blind clinical trial [J]. Evid Based Complement Alternat Med, 2021, 2021: 1632957.
|
| [30] |
Mezzatesta S, Torino C, Meo P, et al. A machine learning-based approach for predicting the outbreak of cardiovascular diseases in patients on dialysis [J]. Comput Methods Programs Biomed, 2019, 177: 9-15.
|
| [31] |
Stuckey TD, Gammon RS, Goswami R, et al. Cardiac phase space tomography: a novel method of assessing coronary artery disease utilizing machine learning [J]. PLoS One, 2018, 13(8): e198603.
|
| [32] |
Cheng P, Waitman LR, Hu Y, et al. Predicting inpatient acute kidney injury over different time horizons: how early and accurate [J]. AMIA Annu Symp Proc, 2018, 2017: 565-574.
|
| [33] |
Ibrahim NE, McCarthy CP, Shrestha S, et al. A clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography [J]. Clin Cardiol, 2019, 42(2): 292-298.
|
| [34] |
Chiu JS, Chong CF, Lin YF, et al. Applying an artificial neural network to predict total body water in hemodialysis patients [J]. Am J Nephrol, 2005, 25(5): 507-513.
|
| [35] |
Guo XY, Zhou W, Shi B, et al. An efficient multiple kernel support vector regression model for assessing dry weight of hemodialysis patients [J]. Curr Bioinform, 2021, 16(2): 284-293.
|
| [36] |
Shie AJ, Lo KH, Lin WT, et al. An integrated model using the Taguchi method and artificial neural network to improve artificial kidney solidification parameters [J]. Biomed Eng Online, 2019, 18(1): 78.
|
| [37] |
Ohara T, Ikeda H, Sugitani Y, et al. Artificial intelligence supported anemia control system (AISACS) to prevent anemia in maintenance hemodialysis patients [J]. Int J Med Sci, 2021, 18(8): 1831-1839.
|
| [38] |
Barbieri C, Molina M, Ponce P, et al. An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients [J]. Kidney Int, 2016, 90(2): 422-429.
|
| [39] |
Kannan S, Morgan LA, Liang B, et al. Segmentation of glomeruli within trichrome images using deep learning [J]. Kidney Int Rep, 2019, 4(7): 955-962.
|
| [40] |
Kolachalama VB, Singh P, Lin CQ, et al. Association of pathological fibrosis with renal survival using deep neural networks [J]. Kidney Int Rep, 2018, 3(2): 464-475.
|